Log in
Log in
Or log in with
GoogleGoogle
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Giovanni Caforio
Age : 57
Public asset : 19,627,429 USD
Country of residence : Unknown
Linked companies : Stryker Corporation - Bristol-Myers Squibb Company

Biography of Giovanni Caforio 
Currently, Giovanni Caforio occupies the position of Chairman & Chief Executive Officer for Bristol Myers Squibb Co. Dr. Caforio is also on the board of Stryker Corp., European Federation of Pharmaceutical Industries & Assns and Hun School of Princeton, Inc. and Member of The Business Roundtable and Member of TJ Holdings LLC. In the past Dr. Caforio held the position of General Manager of Abbott Laboratˇrios Lda., Co-Chairman of Pharmaceutical Research & Manufacturers of America and Member of CEO Roundtable on Cancer, Inc. He received a doctorate from UniversitÓ degli Studi di Roma Tor Vergata.


Current positions of Giovanni Caforio 
Holdings of Giovanni Caforio 
Giovanni Caforio : Personal Network 
Most Read News 
11/28Buffett's Berkshire countersues billionaire Haslams in battle over Pilot valuation
RE
11/30Tesla to deliver Cybertrucks after Musk tempers expectations
MR
11/28Charlie Munger, the 'Oracle of Pasadena' who was Buffett's second-in-command
RE
12/07Elon Musk appeals dispute over SEC consent decree to US Supreme Court
RE
11/27Elon Musk, Netanyahu tour ruins of Israeli kibbutz
RE
11/28Berkshire Hathaway vice chairman Charlie Munger dies at 99
RE
12/06Musk's SpaceX approaches investors for another tender offer - Bloomberg News
RE
11/26Germany's Kuehne examines offer for Signa's Hamburg skyscraper -report
RE
12/07Column-The next big thing in retirement benefits might be the oldest: a traditional pension
RE
12/08Spotify: punished after CFO's departure
CF
More news


© 2023 People and Ownership :   
Giovanni Caforio : Connections 


Latest news about Giovanni Caforio 
11/01Bristol-Myers Squibb Names Christopher Boerner as Chair
MT
10/31Bristol Myers Names Incoming CEO Boerner as Next Chairman
DJ
10/31Bristol Myers Squibb Announces Management Changes
CI
10/26Transcript : Bristol-Myers Squibb Company, Q3 2023 Earnings Call, Oct 26, 2023
CI
10/26Bristol Myers says it needs another year to hit target for new drugs
RE
More news

As early as today, start finding the best investment opportunities!Optimize my profits
Optimize my profits